2013 annual financial data
Xenon Pharmaceuticals 2013 Operating margin
Xenon Pharmaceuticals 2013 operating margin with verified reported values.
Direct answer
Operating margin was 35.5%.
Operating income was 9,712,000 USD and net income was 12,032,000 USD.
Operating cash flow was -3,322,000 USD.
Get free Xenon Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 27,356,000 USD
- Operating income
- 9,712,000 USD
- Net income
- 12,032,000 USD
- Operating cash flow
- -3,322,000 USD